搜尋結果
AbbVie Parkinson’s Drug Rejected by FDA After Plant Inspection
Bloomberg· 14 小時前AbbVie Inc. failed to win approval for a new Parkinson’s disease drug after US regulators found ...
Auckland Surf Park Heated by Data Center Gets Nod From Regulator
Bloomberg· 50 分鐘前US-based surf park developer Aventuur won approval to develop a New Zealand project promising year-round access to waves ...
Nervous Investors Tear Up ESG Playbooks in Election Supercycle
Bloomberg· 3 小時前An anti-green backlash in 2024’s global election-supercycle is already taking a toll on ...
Five Things You Need to Know to Start Your Day: Asia
Bloomberg· 4 小時前Good morning. A rebound in Nvidia shares helped push US stocks higher. India’s central bank is ...
Australia’s Monetary Conditions Are Restrictive, RBA’s Kent Says
Bloomberg· 4 小時前Australia’s monetary settings are restrictive, although the extent to which they have cooled ...
FedEx’s Annual Profit Outlook Beats Estimates on Deep Cost Cuts
Bloomberg· 7 小時前Have a confidential tip for our reporters? FedEx Corp. forecast profit above Wall Street’s ...
The Bill Hwang Tapes and Chats: How 72 Hours Destroyed Archegos
Bloomberg· 6 小時前As Wall Street wakes up, Bill Hwang’s portfolio is poised for a reckoning. As the offering ...
Vietnam’s Coal Plant Plans Draw US Scrutiny After Phase-Out Deal
Bloomberg· 5 小時前Have a confidential tip for our reporters? Plans to build a new coal plant in Vietnam are ...
Milei Dispatches Security Minister Amid Argentine Furor for Missing Child
Bloomberg· 5 小時前President Javier Milei dispatched one of his top ministers to northern Argentina Tuesday as the ...
Vista-Backed Solera Seeks Up to $13 Billion Valuation in IPO
Bloomberg· 5 小時前Vista Equity Partners-backed automotive data and software services provider Solera is set to ...